
Valeant shareholders vent frustrations at drugmaker’s annual meeting
Shareholders in Valeant Pharmaceuticals (TSX:VRX) used the company’s annual general meeting Tuesday as a forum to vent their gripes with the struggling drugmaker. Some stockholders

Valeant shareholders vent frustrations at drugmaker’s annual meeting
Shareholders in Valeant Pharmaceuticals (TSX:VRX) used the company’s annual general meeting Tuesday as a forum to vent their gripes with the struggling drugmaker. Some stockholders
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
OBJ INSIDER HOLIDAY SAVINGS EVENT. See the full story.